Tetra Bio-Pharma Inc., of Ottawa, a cannabinoid-focused company, said it filed a preliminary short form prospectus for a proposed offering of units for minimum gross proceeds of CA$3.5 million (US$2.7 million) and maximum gross proceeds of CA$7 million.